ANKRD1 and polycystic ovary syndrome: The chromatin accessibility of ANKRD1, FZD1, SFRP1, and WNT10B were comparable between PCOS and control samples and generally increased at day 3 followed by decreased accessibility by day 12 (Additional file 2: Supplemental Fig. 7C–F, left panels).